计算溶液所需的质量、体积或浓度。
SB 220025
有货
SB 220025 is a reversible, orally active, cell-permeable, ATP-competitive and selective human p38 MAPK inhibitor ( IC 50 = 60 nM). SB 220025 also inhibits p56 Lck and PKC with IC 50 values of 3.5 and 2.89 µM, respectively. SB 220025 inhibits the expression of IL-8 gene in response to globular adiponectin (gAd), reduces inflammatory cytokine production and inhibits angiogenesis. SB 220025 effectively prevents the progression of arthritis in a chronic inflammatory disease model and can be used in the study of inflammation .
| pKa值 | pKₐ: 9.92 (Predicted) |
|---|---|
| Ki Data | Casein kinase I δ: Ki= 12.59 nM (human); Casein kinase I α: Ki= 12.59 nM (human); Tyrosine-protein kinase LCK: Ki= 125.89 nM (human); PKC ν: Ki= 251.19 nM (human); Lyn: Ki= 316.23 nM (human) |
| IC50 | p38α: IC₅₀= 60 nM (human); ERK 2: IC₅₀= 19 μM (human) |